Last reviewed · How we verify

NCT07228845

Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss

Not yet recruiting NA Last updated 14 November 2025
What this trial tests

NA trial testing BTE hearing aids with compatible ear tips (Third-party, FlexResin, Resin) in Hearing Aids in 32 participants. Not yet recruiting.

Timeline
15 January 2026
Primary endpoint
15 January 2027
15 April 2027

Quick facts

Lead sponsorUniversity of Arizona
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment32
Start date15 January 2026
Primary completion15 January 2027
Estimated completion15 April 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Arizona

Who can join

Adults 18 to 89, any sex, with Hearing Aids or Hearing Loss, Bilateral Sensorineural. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Access to affordable and timely hearing healthcare remains a major challenge for many individuals, partly due to the high cost and long turnaround time. This study will explore whether 3D-printed ear tips perform as well as or better than standard ear tips in terms of sound quality, comfort, and fit over a prolonged duration in a sample of individuals with bilateral hearing loss. It will also compare how long each method takes to make and how much each costs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hearing Aids

Currently open trials in the same condition.

Other University of Arizona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07228845.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing